Terms: = Lung cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118 AND Treatment
10 results:
1. Identification and integration analysis of a novel prognostic signature associated with cuproptosis-related ferroptosis genes and relevant lncRNA regulatory axis in lung adenocarcinoma.
Wang T; Jiang X; Lu Y; Ruan Y; Wang J
Aging (Albany NY); 2023 Mar; 15(5):1543-1563. PubMed ID: 36881404
[TBL] [Abstract] [Full Text] [Related]
2. Hsa_circ_0001073 targets miR-626/lifr axis to inhibit lung cancer progression.
Liu Q; Cao G; Wan Y; Xu C; He Y; Li G
Environ Toxicol; 2021 Jun; 36(6):1052-1060. PubMed ID: 33475233
[TBL] [Abstract] [Full Text] [Related]
3. Does timeliness of care in Non-Small Cell lung cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract] [Full Text] [Related]
4. [Hyponatremia in cancer patients].
Matsuura T
Nihon Jinzo Gakkai Shi; 2012; 54(7):1016-22. PubMed ID: 23234213
[TBL] [Abstract] [Full Text] [Related]
5. Do multidisciplinary team meetings make a difference in the management of lung cancer?
Boxer MM; Vinod SK; Shafiq J; Duggan KJ
Cancer; 2011 Nov; 117(22):5112-20. PubMed ID: 21523766
[TBL] [Abstract] [Full Text] [Related]
6. [Study of use of pemetrexed in non-small cell lung cancer].
Villanueva-Herraiz S; Ortega-García MP; Camps-Herrero C; Blasco-Segura P
Farm Hosp; 2010; 34(4):194-203. PubMed ID: 20594885
[TBL] [Abstract] [Full Text] [Related]
7. A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer.
Gillenwater HH; Stinchcombe TE; Qaqish BF; Tyann M; Hensing TA; Socinski MA
Lung Cancer; 2005 Mar; 47(3):413-9. PubMed ID: 15713525
[TBL] [Abstract] [Full Text] [Related]
8. Sequencing topotecan and etoposide plus cisplatin to overcome topoisomerase I and II resistance: a pharmacodynamically based Phase I trial.
Aisner J; Musanti R; Beers S; Smith S; Locsin S; Rubin EH
Clin Cancer Res; 2003 Jul; 9(7):2504-9. PubMed ID: 12855624
[TBL] [Abstract] [Full Text] [Related]
9. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
Schaefer PL; Marks RS; Mahoney MR; Sloan JA; Bauman MD; Tazelaar HD; Kugler JW; Mailliard JA; Ebbert LP; Wiesenfeld M
Am J Clin Oncol; 2003 Jun; 26(3):236-40. PubMed ID: 12796591
[TBL] [Abstract] [Full Text] [Related]
10. Phase II study of prolonged oral etoposide in combination with intravenous cisplatin in advanced non-small cell lung cancer.
Miller AA; Niell HB; Griffin JP
Lung Cancer; 1995 Mar; 12(1-2):59-65. PubMed ID: 7600031
[TBL] [Abstract] [Full Text] [Related]
